Johnson & Johnson, Teva Pharmaceuticals (NYSE: TEVA), AbbVie (NYSE: ABBV), and Endo International (NASDAQ: ENDP) are currently facing a trial wherein several California counties have sued the businesses for $50 billion for their role in the U.S. opioid epidemic. In an April 27–28 Federal Open Market Committee meeting, several officials suggested the need for plan to tapering the pace of asset purchases to control increasing inflation. Investors are also concerned about the California Department of Motor Vehicles' investigating Tesla for its potentially misleading "full self-driving capability" claim.